BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38626807)

  • 1. The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals.
    Zogopoulos G; Haimi I; Sanoba SA; Everett JN; Wang Y; Katona BW; Farrell JJ; Grossberg AJ; Paiella S; Klute KA; Bi Y; Wallace MB; Kwon RS; Stoffel EM; Wadlow RC; Sussman DA; Merchant NB; Permuth JB; Golan T; Raitses-Gurevich M; Lowy AM; Liau J; Jeter JM; Lindberg JM; Chung DC; Earl J; Brentnall TA; Schrader KA; Kaul V; Huang C; Chandarana H; Smerdon C; Graff JJ; Kastrinos F; Kupfer SS; Lucas AL; Sears RC; Brand RE; Parmigiani G; Simeone DM;
    J Natl Compr Canc Netw; 2024 Apr; 22(3):158-166. PubMed ID: 38626807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance Outcome and Genetic Findings in Individuals at High Risk of Pancreatic Cancer.
    Rosner G; Scapa E; Ziv T; Gluck N; Ben-Yehoyada M
    Clin Transl Gastroenterol; 2024 Feb; 15(2):e00668. PubMed ID: 38147532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?
    Wang Y; Cuggia A; Chen YI; Parent J; Stanek A; Denroche RE; Zhang A; Grant RC; Domecq C; Golesworthy B; Shwaartz C; Borgida A; Holter S; Wilson JM; Chong G; O'Kane GM; Knox JJ; Fischer SE; Gallinger S; Gao ZH; Foulkes WD; Waschke KA; Zogopoulos G
    J Natl Compr Canc Netw; 2022 Jun; 20(6):663-673.e12. PubMed ID: 35714671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
    Langer P; Kann PH; Fendrich V; Habbe N; Schneider M; Sina M; Slater EP; Heverhagen JT; Gress TM; Rothmund M; Bartsch DK
    Gut; 2009 Oct; 58(10):1410-8. PubMed ID: 19470496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry.
    Paiella S; Capurso G; Cavestro GM; Butturini G; Pezzilli R; Salvia R; Signoretti M; Crippa S; Carrara S; Frigerio I; Bassi C; Falconi M; Iannicelli E; Giardino A; Mannucci A; Laghi A; Laghi L; Frulloni L; Zerbi A
    Am J Gastroenterol; 2019 Apr; 114(4):665-670. PubMed ID: 30538291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance.
    Katona BW; Klute K; Brand RE; Everett JN; Farrell JJ; Hawthorne K; Kaul V; Kupfer SS; Paiella S; Simeone DM; Sussman DA; Zogopoulos G; Lucas AL; Kastrinos F;
    Cancer Prev Res (Phila); 2023 Jun; 16(6):343-352. PubMed ID: 37259800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of comprehensive family history and genetic analysis in the multidisciplinary pancreatic tumor clinic setting.
    Everett JN; Dettwyler SA; Jing X; Stender C; Schmitter M; Baptiste A; Chun J; Kawaler EA; Khanna LG; Gross SA; Gonda TA; Beri N; Oberstein PE; Simeone DM
    Cancer Med; 2023 Feb; 12(3):2345-2355. PubMed ID: 35906821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer.
    Paiella S; Capurso G; Carrara S; Secchettin E; Casciani F; Frigerio I; Zerbi A; Archibugi L; Bonifacio C; Malleo G; Cavestro GM; Barile M; Larghi A; Assisi D; Fantin A; Milanetto AC; Fabbri C; Casadei R; Donato G; Sassatelli R; De Marchi G; Di Matteo FM; Arcangeli V; Panzuto F; Puzzono M; Dal Buono A; Pezzilli R; Salvia R; Rizzatti G; Casadio M; Franco M; Butturini G; Pasquali C; Coluccio C; Ricci C; Cicchese N; Sereni G; de Pretis N; Stigliano S; Rudnas B; Marasco M; Lionetto G; Arcidiacono PG; Terrin M; Crovetto A; Mannucci A; Laghi L; Bassi C; Falconi M
    Am J Gastroenterol; 2024 Apr; 119(4):739-747. PubMed ID: 37787643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
    Canto MI; Hruban RH; Fishman EK; Kamel IR; Schulick R; Zhang Z; Topazian M; Takahashi N; Fletcher J; Petersen G; Klein AP; Axilbund J; Griffin C; Syngal S; Saltzman JR; Mortele KJ; Lee J; Tamm E; Vikram R; Bhosale P; Margolis D; Farrell J; Goggins M;
    Gastroenterology; 2012 Apr; 142(4):796-804; quiz e14-5. PubMed ID: 22245846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
    Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
    J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of high-risk individuals for pancreatic cancer with EUS and MRI: A meta-analysis.
    Kogekar N; Diaz KE; Weinberg AD; Lucas AL
    Pancreatology; 2020 Dec; 20(8):1739-1746. PubMed ID: 33077384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic Ultrasound-Based Pancreatic Cancer Screening of High-Risk Individuals: A Prospective Observational Trial.
    Gangi A; Malafa M; Klapman J
    Pancreas; 2018; 47(5):586-591. PubMed ID: 29683970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of "gene-environment" interaction in cases of familial and sporadic pancreatic cancer.
    Yeo TP; Hruban RH; Brody J; Brune K; Fitzgerald S; Yeo CJ
    J Gastrointest Surg; 2009 Aug; 13(8):1487-94. PubMed ID: 19459017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Progression of Pancreatic Cystic Precursor Lesions Differ Between Groups at High Risk of Developing Pancreatic Cancer.
    Konings IC; Harinck F; Poley JW; Aalfs CM; van Rens A; Krak NC; Wagner A; Nio CY; Sijmons RH; van Dullemen HM; Vleggaar FP; Ausems MG; Fockens P; van Hooft JE; Bruno MJ;
    Pancreas; 2017 Jan; 46(1):28-34. PubMed ID: 27846136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for pancreatic cancer in familial high-risk individuals: A systematic review.
    Lu C; Xu CF; Wan XY; Zhu HT; Yu CH; Li YM
    World J Gastroenterol; 2015 Jul; 21(28):8678-86. PubMed ID: 26229410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial pancreatic cancer: Concept, management and issues.
    Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
    World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in precursor lesions of pancreatic cancer among high-risk groups.
    Potjer TP; Schot I; Langer P; Heverhagen JT; Wasser MN; Slater EP; Klöppel G; Morreau HM; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bargello M; Gress TM; Vasen HF; Bartsch DK; ;
    Clin Cancer Res; 2013 Jan; 19(2):442-9. PubMed ID: 23172884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of Individuals with a Family History of Pancreatic Cancer and Inherited Cancer Syndromes: A Strategy for Detecting Early Pancreatic Cancers.
    Matsubayashi H; Kiyozumi Y; Ishiwatari H; Uesaka K; Kikuyama M; Ono H
    Diagnostics (Basel); 2019 Oct; 9(4):. PubMed ID: 31683730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consortium.
    Huang C; Simeone DM; Luk L; Hecht EM; Khatri G; Kambadakone A; Chandarana H; Ream JM; Everett JN; Guimaraes A; Liau J; Dasyam AK; Harmath C; Megibow AJ;
    AJR Am J Roentgenol; 2022 Dec; 219(6):903-914. PubMed ID: 35856454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.